Sylvia Shenouda
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 2%
- Cancer Research top 5%
- Surgery
- Pharmacology top 5%
- Co-authors
- Suresh K. AlahariCory R. HeilmannJohn B. BuseByron J. HoogwerfWayne H.-H. SheuMichael A. NauckAijun GaoThomas Först
- Topics
- Diabetes Management and Research (4 papers)Diabetes Treatment and Management (4 papers)Neurotransmitter Receptor Influence on Behavior (4 papers)
- Partner nations
- United StatesBrazilAustria
In The Last Decade
Sylvia Shenouda
16 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Biology 909
- Endocrinology, Diabetes and Metabolism 621
- Cancer Research 481
- Surgery 239
- Pharmacology 199
Countries citing papers authored by Sylvia Shenouda
This map shows the geographic impact of Sylvia Shenouda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Shenouda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Shenouda more than expected).
Fields of papers citing papers by Sylvia Shenouda
This network shows the impact of papers produced by Sylvia Shenouda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Shenouda. The network helps show where Sylvia Shenouda may publish in the future.
Co-authorship network of co-authors of Sylvia Shenouda
This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Shenouda. A scholar is included among the top collaborators of Sylvia Shenouda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Shenouda. Sylvia Shenouda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 59 | |
| 3 | Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label studybreakdown → | 460 |
| 4 | 33 | |
| 5 | 63 | |
| 6 | 52 | |
| 7 | 64 | |
| 8 | 19 | |
| 9 | 62 | |
| 10 | 1 | |
| 11 | MicroRNA function in cancer: oncogene or a tumor suppressor?breakdown → | 563 |
| 12 | 28 | |
| 13 | 27 | |
| 14 | 5 | |
| 15 | 97 | |
| 16 | 3 | |
| 17 | 22 |
About Sylvia Shenouda
Sylvia Shenouda is a scholar working on Toxicology, Endocrinology, Diabetes and Metabolism and Behavioral Neuroscience, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (621 citations), Cancer Research (481 citations) and Toxicology (61 citations). Sylvia Shenouda has collaborated with scholars based in United States, Brazil and Austria. Frequent co-authors include Suresh K. Alahari, Cory R. Heilmann, John B. Buse, Byron J. Hoogwerf, Wayne H.-H. Sheu, Michael A. Nauck, Aijun Gao, Thomas Först, Mark Fineman and Guntram Schernthaner. Their work appears in journals such as The Lancet, Diabetes Care and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.